288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors

288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors

Bibliographic Details
Main Authors: Bhumsuk Keam, Chan-Young Ock, Tae Min Kim, Do-Youn Oh, Jeeyun Lee, Won Ki Kang, Yeon Hee Park, Ji Hye Lee, Yun Jeong Song, Young Suk Park
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items